Skip to main content
. 2020 Aug 31;6(8):e04803. doi: 10.1016/j.heliyon.2020.e04803

Table 2.

Physician survey: Potential barriers to guideline adherence (13 items, [Abbreviation]).

Potential Barriers (B) for Guideline Adherence
B1 The patient is not able to adequately manage diabetes (e.g. lack of education, cognitive deficiencies, psychosocial problems) [Patient Inability].
B2 The patient is not ready or motivated to adequately manage diabetes (especially for lifestyle aspects like diet or exercise) [Patient Demotivation].
B3 The patient does not consent to guideline adherent treatment (e.g. antipathy against insulin, fear of side effects) [Patient Refusal].
B4 The physician does not have all relevant clinical information (e.g. most recent lab panel, medication) at the time of therapy decision [Missing Clinical Information].
B5 The organization of the healthcare system is not well suited for T2DM care [Health Care System Deficiencies].
B6 Guideline adherent therapy is not possible for medical reasons (e.g. contraindication) [Medical Reasons].
B7 Patients and physicians do not cooperate well in therapy (e.g. missed appointments) [Patient-Physician Relationship].
B8 The aims of the guideline are not aligned with the structure of the reimbursement system. [Nonalignment of Guideline and Reimbursement].
B9 The physician is not sufficiently informed about the guideline or trained in its use [Deficient Physician Training].
B10 The physician disagrees with the guideline recommendation (on certain points). [Physician Disapproval with Guideline]
B11 Due to high workload, the physician cannot devote enough time to the individual patient [High Physician Workload]
B12 There is a lack of effective coordination between care providers (e.g. outpatient/inpatient, GP/specialist) [Deficient cross-sectional Coordination].
B13 The physician lacks the necessary self-confidence to initiate complex therapy regimes - especially pharmaco- and insulin therapy [Deficient therapeutic Self-Confidence]